These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 301778)

  • 21. High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.
    Djerassi I; Kim JS; Shulman K
    Cancer Treat Rep; 1977 Jul; 61(4):691-4. PubMed ID: 301782
    [No Abstract]   [Full Text] [Related]  

  • 22. Growth rate and cell kill.
    Hryniuk WM; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():330-42. PubMed ID: 5289425
    [No Abstract]   [Full Text] [Related]  

  • 23. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance.
    Sirotnak FM; Poser RE; Barrueco JR
    Cancer Res; 1987 Oct; 47(20):5334-9. PubMed ID: 3498533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose methotrexate with folinic acid rescue.
    Bender JF; Grove WR; Fortner CL
    Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eradication of leukaemic cells (L1210) by methotrexate and methotrexate plus citrovorum factor.
    Goldin A; Venditti JM; Kline I; Mantel N
    Nature; 1966 Dec; 212(5070):1548-50. PubMed ID: 21105503
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antineoplastic activity of antibiotic 1719 from the group of diazo compounds].
    Shorin VA; Averbukh LA; Bazhanov VS; Lepeshkina GN; Grinshteĭn AM
    Antibiotiki; 1972 Aug; 17(8):675-80. PubMed ID: 4678532
    [No Abstract]   [Full Text] [Related]  

  • 27. Identical efficacy of methotrexate regimens with N5-methyltetrahydrofolate rescue or with leucovorin rescue for treatment of L1210 murine leukemia.
    Nixon PF; Wilson L
    Cancer Treat Rep; 1983 Jan; 67(1):59-62. PubMed ID: 6604578
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute toxicity of methotrexate and cyclophosphamide in mice inoculated with malignant neoplasms.
    Graczyk J
    Pol J Pharmacol Pharm; 1981; 33(1):73-80. PubMed ID: 7255281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
    Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
    Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.
    Isacoff WH; Eilber F; Tabbarah H; Klein P; Dollinger M; Lemkin S; Sheehy P; Cone L; Rosenbloom B; Sieger L; Block JB
    Cancer Treat Rep; 1978 Sep; 62(9):1295-304. PubMed ID: 356984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical use of methotrexate--with emphasis on use of high doses.
    Bertino JR
    Cancer Treat Rep; 1981; 65 Suppl 1():131-5. PubMed ID: 6976829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate. II. Use in pediatric chemotherapy.
    Lippens RJ
    Am J Pediatr Hematol Oncol; 1984; 6(4):397-413. PubMed ID: 6398630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration.
    Von Hoff DD; Penta JS; Helman LJ; Slavik M
    Cancer Treat Rep; 1977 Jul; 61(4):745-8. PubMed ID: 301783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Weekly high-dose methotrexate with citrovorum factor rescue for non-Hodgkin's lymphoma--serum methotrexate level and safety administration (author's transl)].
    Sasaki K; Fujimoto T; Goya N
    Rinsho Ketsueki; 1979 Jan; 20(1):90-7. PubMed ID: 311390
    [No Abstract]   [Full Text] [Related]  

  • 35. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
    Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
    Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the in vivo synthesis of methotrexate polyglutamates and their efflux properties in normal, proliferative, and neoplastic mouse tissues.
    Poser RG; Sirotnak FM
    Adv Exp Med Biol; 1983; 163():259-74. PubMed ID: 6193689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia.
    Klubes P; Cerna I
    Cancer Treat Rep; 1981; 65(1-2):107-14. PubMed ID: 7226161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of antifolates and folates on the antineoplastic action of fluoropyrimidines].
    Graczyk J
    Postepy Hig Med Dosw; 1992; 46(2):143-58. PubMed ID: 1470578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New "rescue" with massive doses of citrovorum factor for potentially lethal methotrexate toxicity.
    Djerassi I; Kim JS; Nayak N; Ohanissian H; Adler S; Hsieh S
    Cancer Treat Rep; 1977 Jul; 61(4):749-50. PubMed ID: 301784
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of therapeutic synergism between vincristine and methotrexate in L1210 murine leukemia in vivo.
    Bender RA; Nichols AP; Norton L; Simon RM
    Cancer Treat Rep; 1978 Jul; 62(7):997-1003. PubMed ID: 688252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.